SCHEMBL3851554

SCHEMBL3851554

Fc1ccc(-c2n[nH]cc2-c2ccc3ncc(-c4noc(C5CC5c5ccccc5)n4)n3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.36
PIK3CA P42336 3/20 0.35
S1PR1 P21453 1/20 0.35
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34
CDK19 Q9BWU1 1/20 0.34
JAK2 O60674 3/20 0.33
JAK3 P52333 3/20 0.33
JAK1 P23458 2/20 0.33
FLT3 P36888 3/20 0.33
KIT P10721 4/20 0.33
KCNT2 Q6UVM3 1/20 0.32
NRAS P01111 1/20 0.32
LMNA P02545 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3855309 0.86 TGFBR1 (0.38) TGFBR1PIK3CAJAK2JAK3JAK1
Hydrochloric Acid SCHEMBL3854861 0.85 TGFBR1 (0.37) TGFBR1PIK3CAJAK2JAK3JAK1
Hydrochloric Acid SCHEMBL3846121 0.85 TGFBR1 (0.37) TGFBR1PIK3CAJAK2JAK3JAK1
Hydrochloric Acid SCHEMBL3847409 0.83 ALDH1A1 (0.40) TGFBR1PIK3CAS1PR1PIK3CBMTOR
SCHEMBL3848981 0.83 PIK3CA (0.33) TGFBR1PIK3CAS1PR1PIK3CBMTOR
SCHEMBL3847576 0.81 PIK3CA (0.49) TGFBR1PIK3CAPIK3CBMTORCDK19
Hydrochloric Acid SCHEMBL3846443 0.78 CNR2 (0.41) TGFBR1PIK3CAPIK3CBMTORCDK19
SCHEMBL3850704 0.78 FLT3 (0.43) TGFBR1JAK2JAK3JAK1FLT3
SCHEMBL3848982 0.77 PIK3CA (0.31) PIK3CAPIK3CBMTORCDK19
SCHEMBL3846083 0.77 TGFBR1 (0.38) TGFBR1PIK3CAFLT3KITNRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed